These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12678757)

  • 1. Advances in the chemistry and pharmacology of ecteinascidins, a promising new class of anti-cancer agents.
    Manzanares I; Cuevas C; García-Nieto R; Marco E; Gago F
    Curr Med Chem Anticancer Agents; 2001 Nov; 1(3):257-76. PubMed ID: 12678757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and crystal structures of ecteinascidins: potent antitumor compounds from the Caribbean tunicate Ecteinascidia turbinata.
    Guan Y; Sakai R; Rinehart KL; Wang AH
    J Biomol Struct Dyn; 1993 Apr; 10(5):793-818. PubMed ID: 8318161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata.
    Pommier Y; Kohlhagen G; Bailly C; Waring M; Mazumder A; Kohn KW
    Biochemistry; 1996 Oct; 35(41):13303-9. PubMed ID: 8873596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional antitumor ecteinascidins from a Caribbean tunicate: crystal structures and activities in vivo.
    Sakai R; Rinehart KL; Guan Y; Wang AH
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11456-60. PubMed ID: 1454834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Yondelis (trabectedin, ET-743). A semisynthetic process solves the supply problem.
    Cuevas C; Francesch A
    Nat Prod Rep; 2009 Mar; 26(3):322-37. PubMed ID: 19240944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics.
    Le VH; Inai M; Williams RM; Kan T
    Nat Prod Rep; 2015 Feb; 32(2):328-47. PubMed ID: 25273374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemistry of ecteinascidins. Part 4: preparation of 2'-N-acyl ecteinascidin 770 derivatives with improved cytotoxicity profiles.
    Tsujimoto M; Lowtangkitcharoen W; Mori N; Pangkruang W; Putongking P; Suwanborirux K; Saito N
    Chem Pharm Bull (Tokyo); 2013; 61(10):1052-64. PubMed ID: 24088697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical pharmacology of ecteinascidin 729, a marine natural product with potent antitumor activity.
    Reid JM; Walker DL; Ames MM
    Cancer Chemother Pharmacol; 1996; 38(4):329-34. PubMed ID: 8674155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor compounds from tunicates.
    Rinehart KL
    Med Res Rev; 2000 Jan; 20(1):1-27. PubMed ID: 10608919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic studies on ecteinascidin-743: constructing a versatile pentacyclic intermediate for the synthesis of ecteinascidins and saframycins.
    Jin W; Metobo S; Williams RM
    Org Lett; 2003 Jun; 5(12):2095-8. PubMed ID: 12790537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical Research on Antitumor Isoquinoline Marine Natural Products and Related Compounds.
    Saito N
    Chem Pharm Bull (Tokyo); 2021; 69(2):155-177. PubMed ID: 33518599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry of ecteinascidins. Part 3: preparation of 2'-N-acyl derivatives of ecteinascidin 770 and evaluation of cytotoxicity.
    Saktrakulkla P; Toriumi S; Tsujimoto M; Patarapanich C; Suwanborirux K; Saito N
    Bioorg Med Chem; 2011 Aug; 19(15):4421-36. PubMed ID: 21752654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potent anticancer compound ecteinascidin-743 (ET-743) as its 2-propanol disolvate.
    Sainz-Diaz CI; Manzanares I; Francesch A; Garcia-Ruiz J
    Acta Crystallogr C; 2003 Apr; 59(Pt 4):O197-8. PubMed ID: 12682407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ecteinascidin 743: a minor groove alkylator that bends DNA toward the major groove.
    Zewail-Foote M; Hurley LH
    J Med Chem; 1999 Jul; 42(14):2493-7. PubMed ID: 10411470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trabectedin: Ecteinascidin 743, Ecteinascidin-743, ET 743, ET-743, NSC 684766.
    Drugs R D; 2006; 7(5):317-28. PubMed ID: 16922593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemistry of Ecteinascidins. Part 5: An Additional Proof of Cytotoxicity Evaluation of Ecteinascidin 770 Derivatives.
    Toyoshima R; Mori N; Suzuki T; Lowtangkitcharoen W; Suwanborirux K; Saito N
    Chem Pharm Bull (Tokyo); 2016; 64(7):966-9. PubMed ID: 27373655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemistry of ecteinascidins. Part 2. Preparation of 6'-O-acyl derivatives of stable ecteinascidin and evaluation of cytotoxicity.
    Puthongking P; Patarapanich C; Amnuoypol S; Suwanborirux K; Kubo A; Saito N
    Chem Pharm Bull (Tokyo); 2006 Jul; 54(7):1010-6. PubMed ID: 16819221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical and clinical results with the natural marine product ET-743.
    D'Incalci M; Jimeno J
    Expert Opin Investig Drugs; 2003 Nov; 12(11):1843-53. PubMed ID: 14585059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecteinascidins 770 and 786 from the Thai tunicate Ecteinascidia thurstoni.
    Suwanborirux K; Charupant K; Amnuoypol S; Pummangura S; Kubo A; Saito N
    J Nat Prod; 2002 Jun; 65(6):935-7. PubMed ID: 12088444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inefficiency of incisions of ecteinascidin 743-DNA adducts by the UvrABC nuclease and the unique structural feature of the DNA adducts can be used to explain the repair-dependent toxicities of this antitumor agent.
    Zewail-Foote M; Li VS; Kohn H; Bearss D; Guzman M; Hurley LH
    Chem Biol; 2001 Nov; 8(11):1033-49. PubMed ID: 11731295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.